Artex (NSAID)

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Artex (NSAID)


Quick Facts about Artex (Meloxicam)

Property Description
Active ingredient Meloxicam
Form Tablet, Solution for injection, Oral suspension
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common purpose Symptomatic relief from inflammation, pain, and fever
Origin Synthetic compound (Oxicam derivative)

Defining Artex: Identity and Pharmacological Classification

Artex is a well-recognized trade name for a medicinal preparation whose active component is Meloxicam, a chemically synthetic compound categorized as an Oxicam derivative. It is a prescription-only drug (Rx) that belongs to the group of Nonsteroidal Anti-inflammatory Drugs (NSAIDs). Artex is clinically recognized for its primary role as an Anti-inflammatory agent, complemented by its properties as an Analgesic (pain reliever) and an Antipyretic (fever reducer).

The active ingredient, Meloxicam, is distinguished by its mechanism as a preferential cyclooxygenase-2 (COX-2) inhibitor. This property allows Meloxicam to be utilized for its capacity to provide balanced, comprehensive systemic relief.

What is the Composition and Type of Artex (Meloxicam)?

Artex is a single active ingredient preparation, ensuring that all therapeutic effects derive solely from the Meloxicam compound. The medication is offered in several pharmaceutical dosage forms to suit varied requirements, commonly including the tablet (oral form), oral suspension, and a sterile solution for injection (parenteral form).

The availability of these different preparations ensures flexibility in systemic delivery, allowing for administration by the oral route as well as via intramuscular injection. Meloxicam is categorized within the anti-inflammatory and anti-rheumatic products, establishing the drug’s intended therapeutic framework for mitigating bodily inflammation.

General Purpose of Artex: Relief from Inflammation and Pain

The overarching purpose of using Artex is to provide symptomatic relief by effectively mitigating the physical expressions of the inflammatory process. The substance achieves this by inhibiting the formation of key inflammatory compounds known as prostaglandins. This targeted action is fundamental in reducing swelling, alleviating tenderness, and helping to moderate an elevated body temperature. For instance, in a patient experiencing significant discomfort, Artex is used to diminish local inflammation and associated pain, allowing for improved comfort.

What side effects are possible with Artex (NSAID)?

Possible Side Effects and Safety Information

The safety profile for Artex (NSAID) is officially documented by government health authorities, detailing adverse reactions by severity, frequency, and affected body system. This information is non-advisory and strictly based on regulatory classifications.

Frequency and Body System Classification

Adverse reactions are organized into System-Organ Classes (SOCs) such as Gastrointestinal Disorders, Cardiovascular Disorders, Nervous System Disorders, and Renal and Urinary Disorders. Frequency is formally classified (e.g., Very Common, Common, Uncommon, Rare, Very Rare, Not Known) to indicate how often a reaction may occur based on clinical data.

Documented Serious Adverse Reactions

The most serious, clinically significant risks explicitly stated in regulatory labels include:

  • Serious Cardiovascular Thrombotic Events: Including Myocardial Infarction (heart attack) and Stroke, which can be fatal. This risk may occur early in treatment and can increase with longer duration of use.
  • Serious Gastrointestinal Events: Such as inflammation, bleeding, ulceration, and perforation of the stomach or intestines, which can also be fatal and may occur without warning.
  • Hepatotoxicity and Severe Skin Reactions: Documented risks include liver failure and severe dermatological reactions (e.g., Stevens-Johnson Syndrome).

Safety Constraints and Specific Populations

Regulatory documents impose specific restrictions and constraints on the use of Artex:

  • Duration and Dose: Patients are officially constrained to use the lowest effective dose for the shortest duration possible to minimize the potential for CV and GI risks.
  • Pregnancy: Artex is contraindicated during the third trimester of pregnancy. Use at or after 20 weeks gestation is associated with a risk of fetal renal dysfunction.
  • Contraindications: Use is restricted in patients immediately following Coronary Artery Bypass Graft (CABG) surgery and in those with severe, uncontrolled heart failure or pre-existing NSAID hypersensitivity.

This structure ensures that the full spectrum of documented risks—from common side effects to rare, serious events and population-specific risks—is officially communicated.

Overdose and Emergency Response

Overdose and When to Seek Help

Artex belongs to the class of nonsteroidal anti-inflammatory drugs (NSAIDs), and overdose is associated with severe risks affecting multiple physiological systems. Official regulatory information highlights the potential for serious outcomes, including fatal cardiovascular (CV) thrombotic events (such as myocardial infarction and stroke) and serious gastrointestinal (GI) adverse events (including bleeding, ulceration, and perforation).

Documented Overdose Presentations

Acute overdose may present with gastrointestinal symptoms (nausea, vomiting, epigastric pain). At high doses, more critical clinical manifestations reported include seizures, metabolic acidosis, coma, acute renal failure, and hypotension.

When Immediate Medical Attention is Required

NSAIDs increase the likelihood of life-threatening events, with the risk potentially increasing with longer use and higher doses. Immediate medical attention must be sought if any of the following symptoms occur, as they can indicate a serious event:

  • Chest pain
  • Sudden shortness of breath or trouble breathing
  • Weakness or numbness in one part or side of the body
  • Slurred speech

Additionally, stop the medication and contact a healthcare provider right away if symptoms of severe GI or hepatic injury occur, such as vomiting blood or jaundice (skin/eyes looking yellow).

Therapeutic Uses of Artex (NSAID)

What Artex (NSAID) treats: main uses and benefits

Artex, which contains Meloxicam, is considered relevant across therapeutic domains where additional symptomatic support is needed, primarily to ease the overall symptom burden associated with inflammatory or irritative states. This medication is commonly used to help with the signs and symptoms of major forms of arthritis.

Supportive Relief for Inflammatory Conditions

This medication is generally applied in the long-term management of conditions characterized by periods of heightened symptoms, such as Osteoarthritis (OA), Rheumatoid Arthritis (RA), and Ankylosing Spondylitis (AS). It is also relevant for episodes of sudden symptom escalation, including acute gouty arthritis flares. Artex assists with managing symptom clusters that may become intense or disruptive, including symptoms related to physical discomfort (pain), tenderness, and stiffness. This supportive relief may help patients cope more steadily with symptom fluctuations and assists with maintaining functional stability when symptoms interfere with routine activities.

“Artex is commonly used to help with the signs and symptoms of major forms of arthritis, supporting the reduction of discomfort and stiffness.”


Quick Fact: Relief for Inflammatory Symptoms
Primary Focus Symptoms related to inflammatory or irritative states
Symptom Axes Physical discomfort, functional strain, joint stiffness
Use Context Long-term management and acute symptom intervention

Regulatory References

  1. NIH MedlinePlus overview of Meloxicam

Eligibility and Restrictions for Use

Artex (meloxicam) is a nonsteroidal anti-inflammatory drug (NSAID) primarily used to treat the pain and inflammation associated with osteoarthritis and rheumatoid arthritis. It is generally prescribed for adults and is sometimes used in adolescents and children over two years old for juvenile rheumatoid arthritis, based on specific dosing by body weight.


Contraindications

Artex should not be used in patients with the following conditions, as it can increase the risk of serious or potentially fatal complications:

  • Known Allergy: History of asthma, hives (urticaria), or allergic-type reactions after taking aspirin or any other NSAID.
  • Cardiovascular Conditions: Use right before or immediately following coronary artery bypass graft (CABG) surgery; existing severe heart failure.
  • Gastrointestinal Bleeding: Active stomach or intestinal bleeding, ulcers, or a history of severe gastrointestinal issues related to NSAID use.
  • Pregnancy: During the third trimester of pregnancy (around 30 weeks and later) due to the risk of harm to the fetus.
  • Severe Organ Impairment: Severe or advanced kidney failure.

Caution for High-Risk Groups

Use of Artex requires careful medical review and monitoring in people with a history of hypertension (high blood pressure), mild to moderate heart failure, risk factors for cardiovascular disease (e.g., high cholesterol, diabetes, or smoking), liver or kidney disease, or in those taking anticoagulants, aspirin, or other medications that may interact with NSAIDs. Elderly patients (age 65 and older) are generally at increased risk for adverse effects.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the documented interactions of Artex (NSAID) with other medicines and substances, as established in regulatory labeling. The co-administration of Artex with certain agents may alter drug exposure or result in additive effects on specific physiological systems.


Documented Interaction Categories

Interaction Type Interacting Agent Categories
Pharmacodynamic Interactions Oral Anticoagulants (e.g., Warfarin), Antiplatelet Agents, Corticosteroids, SSRIs/SNRIs
Renal/Transport Interactions Lithium, Methotrexate, Diuretics, ACE Inhibitors, ARBs
Metabolic (CYP) Interactions Strong CYP2C9 Inhibitors (e.g., Fluconazole), CYP2C9 Inducers

Summary of Restrictions and Effects

  • Contraindicated Combinations: Co-administration with other non-aspirin NSAIDs is restricted. Use is also restricted around the time of Coronary Artery Bypass Graft (CABG) surgery.
  • Increased Risk of Bleeding: Combining Artex with anticoagulants, antiplatelet agents, corticosteroids, or SSRIs/SNRIs significantly increases the documented risk of bleeding.
  • Exposure Modification: Strong CYP2C9 inhibitors increase Artex plasma levels, potentially requiring dose adjustment. Conversely, CYP2C9 inducers may reduce Artex exposure.
  • Reduced Efficacy: Artex can diminish the antihypertensive and diuretic effects of ACE inhibitors, ARBs, and diuretics.
  • Increased Toxicity: Artex reduces the renal clearance of both Lithium and Methotrexate, leading to elevated plasma concentrations of these medicines and a documented risk of toxicity.
  • Other Substances: Alcohol consumption during therapy is associated with an increased risk of gastrointestinal adverse effects.

Mechanism of Action

Preferential Inhibition of the Prostaglandin Synthesis Pathway

This core mechanism involves the drug acting as a reversible inhibitor to preferentially block the activity of the inducible COX-2 enzyme, which synthesizes chemical mediators, such as prostaglandins, from arachidonic acid. This targeted suppression of the prostaglandin synthesis pathway is the molecular action that underpins the drug's resultant physiological changes.

Modulation of Afferent Nerve and Thermoregulatory Signaling

The reduction of pro-inflammatory prostaglandins functionally impacts two critical physiological systems: it reduces the chemical sensitivity of peripheral nerve endings, altering nociceptor activation thresholds, and it influences the central mechanism in the hypothalamus, thereby modulating the body's thermostatic set-point. This mechanistic cascade leads to resultant physiological changes in afferent nerve sensitivity and core body temperature regulation.

The Constraint of Dose-Dependent COX-1 Interaction

The mechanism's specificity is subject to constraints, as the drug's binding to the constitutive COX-1 enzyme is concentration-dependent. The inhibition of this enzyme increases at higher plasma levels, potentially engaging mechanisms that regulate COX-1-dependent homeostatic processes.

Dosage and Administration Information

How to Use Artex (NSAID)

The following information outlines general administration principles for nonsteroidal anti-inflammatory drugs (NSAIDs).

Dosing and Route of Administration

Instruction Category Requirement
Route Primarily Oral (by mouth) for tablets, capsules, or suspensions. Other authorized routes (e.g., intravenous or topical) apply only to specific formulations.
General Dosing Rule Use the lowest effective dosage for the shortest duration to meet individual patient goals.
Maximum Dose The total quantity of medicine taken must not exceed the specified maximum dose in a 24-hour period (e.g., adult prescription limits often range up to 3200 mg, depending on the specific NSAID).
Frequency Adherence to the time interval between doses as directed is necessary (e.g., every 4 to 6 hours or once daily), without taking two doses simultaneously.

Administration Procedures and Special Populations

  • With Food/Liquid: The oral dosage form may be taken with food, milk, or a full glass of water, which is often recommended to mitigate digestive upset associated with this class of medication.
  • Preparation: Tablets and capsules are generally swallowed whole; extended-release or delayed-release forms must not be crushed, split, or chewed.
  • Missed Dose: If a dose is missed and it is almost time for the next scheduled dose, the missed dose is typically skipped. A double dose should not be taken to compensate.
  • Age-Specific Rules: For older adults (e.g., 65 years and older), lower starting doses and short-term use are typically recommended. Pediatric dosing is based on body weight or age and follows established clinical guidelines.

Administration Protocol

These instructions establish a structured administration protocol, ensuring the medicine is used according to the precise quantity, frequency, and method appropriate for the therapeutic framework.

Recent Clinical Evidence

Research evidence / Overview of studies for Artex (NSAID)

Evidence for Use in Osteoarthritis and Rheumatoid Arthritis

Research has focused on patterns of symptom change associated with Artex use in adults who have conditions characterized by fluctuating or episodic manifestations, specifically Osteoarthritis (OA) and Rheumatoid Arthritis (RA). These investigations were primarily conducted through short-term, randomized controlled trials (RCTs) and meta-analyses. Researchers applied these studies to examine patient-reported experiences and defined outcomes related to physical discomfort and systemic or functional imbalance. To measure defined outcomes, studies monitored established scales like the WOMAC index for OA and the ACR response criteria for RA.

The findings describe patterns observed in the studies related to the defined outcomes, such as changes measured in patient-reported scores across the short-term trial periods. This research contributes to the broader evidence landscape by helping to contextualize how patients reported their experience during periods of up to 6 months of use.

Evidence for Use in Ankylosing Spondylitis and Acute Pain Syndromes

The evidence base for Ankylosing Spondylitis (AS) was evaluated in studies tracking changes using criteria similar to those for RA, focusing on conditions involving periods of heightened symptoms and functional strain. Separately, Artex was evaluated in research exploring certain acute pain syndromes, such as those experienced following specific surgical procedures or associated with acute low back pain.

In the acute pain research scenarios, studies reported patterns of change in measurements of pain intensity difference relative to placebo over short intervals, typically the immediate 24 to 72 hours following initiation of the compound. Evidence suggests that the patterns observed in the studies varied across different types of acute pain, and the research provides insight into short-term changes only.

Understanding the Evidence Gaps and Limitations

The research describes what has been observed so far, but also highlights areas where limited information for long-term outcomes exists, particularly concerning the maintenance of symptomatic patterns beyond the short-term trial window. The results apply only to the populations studied, and evidence quality varies across studies, leading to some subgroup findings that are uncertain. Research does not determine whether an individual will respond similarly to the group patterns described in the study reports.

Frequently Asked Questions (FAQ)

Common questions about Artex (NSAID) (FAQ)


Q: Does Artex affect your sleep?

Official product labeling for Artex lists insomnia, which is difficulty sleeping, as an uncommon side effect. Conversely, drowsiness or excessive sleepiness (somnolence) is noted as a rare side effect under nervous system disorders. These are documented potential occurrences, but they are not typically listed among the most common adverse effects.


Q: Is it normal to feel a little dizzy after taking Artex?

According to the official product information, dizziness is documented as a common adverse reaction associated with Artex. Common adverse reactions are defined as typically occurring in 1% to 10% of patients who use the medication. If any side effect, including dizziness, is concerning, it should be discussed with a healthcare professional.


Q: Can Artex cause stomach issues, and if so, how can it be minimized?

Artex belongs to the NSAID class, and these medications can potentially cause gastrointestinal (GI) side effects like heartburn or abdominal pain. To help mitigate the potential for digestive upset, official documentation recommends that the medication may be taken with food, milk, or a full glass of water. This is a general administration guideline often followed to help mitigate the potential for digestive upset.


Q: Can Artex be taken while using common over-the-counter cold medicines?

Regulatory documents explicitly restrict the co-administration of Artex with other non-aspirin Nonsteroidal Anti-inflammatory Drugs (NSAIDs). Many common over-the-counter cold and flu medicines contain an NSAID, which can increase the risk of serious side effects if taken concurrently. A review of the ingredients in any concurrent medication is part of safe medication use.


Q: Is Artex addictive?

The official product labeling and regulatory classifications for Artex, and the class of NSAID drugs it belongs to, do not classify it as a controlled substance. The medication does not carry warnings regarding abuse potential or the development of physical dependence.


Q: Does Artex have a sedative effect?

Artex is not primarily categorized as a sedative drug. However, official labeling lists drowsiness (somnolence) as a rare central nervous system adverse reaction. Sedative effects are not among the commonly expected side effects of this medication.


Q: Is Artex recommended for period pain (menstrual cramps)?

Artex (meloxicam) is officially indicated for the relief of pain and inflammation associated with conditions such as osteoarthritis and rheumatoid arthritis. Specific mention of primary dysmenorrhea (menstrual cramps or period pain) is not listed as an approved indication in the core regulatory labeling.


Q: Does taking Artex regularly reduce the overall inflammation in the body?

The approved purpose of Artex is to provide symptomatic relief by inhibiting the formation of prostaglandins, which are key chemical mediators in the inflammatory process. Its approved purpose is to provide symptomatic relief by helping to mitigate the physical expressions of inflammation, pain, and tenderness.


Q: If I have mild pain, is it better to take a lower dose of Artex?

The official General Dosing Rule for Artex requires using the lowest effective dosage for the shortest duration consistent with the regulatory label. This general principle guides prescribers to minimize potential risks while still seeking to achieve the desired therapeutic effect.


Q: How long does Artex stay in your system after the last dose?

According to the regulatory pharmacology documentation, the half-life of the active ingredient (Meloxicam) in Artex is approximately 15 to 20 hours. The half-life is the time it takes for half of the drug to be eliminated from the bloodstream and is a key factor in determining how long the substance remains in the body.


Q: Why does Artex sometimes cause heartburn?

Heartburn is explicitly listed in the regulatory documents as a common gastrointestinal adverse reaction to Artex. NSAIDs, in general, can cause these side effects by affecting the protective lining of the stomach and digestive tract.


Q: Can Artex be used to reduce fever?

Yes, Artex is classified as an antipyretic, which means it has fever-reducing properties. Its mechanism is documented to involve modulating the body's thermostatic set-point, which allows it to help in moderating an elevated body temperature.


Q: Are there any common foods that interact negatively with Artex?

The official regulatory labeling does not explicitly restrict any common foods; in fact, it is noted that the oral form of Artex may be taken with food, milk, or water. There is a specific warning, however, that alcohol consumption is associated with an increased risk of gastrointestinal adverse effects.


Q: Is there a generic version of Artex available?

The active ingredient in Artex, which is Meloxicam, is available as a generic medicine in many markets once patent exclusivity has ended. Generic versions are required by regulatory bodies to contain the same active ingredient and meet the same standards for quality and performance as the brand-name drug.


Q: Can people with stomach ulcers use Artex safely?

Artex is restricted from use (contraindicated) in patients with active stomach or intestinal bleeding or active ulcers. Furthermore, official warnings state that people with a prior history of peptic ulcer disease have a significantly increased risk for developing a GI bleed if they use NSAIDs.


Q: What should I do if I think I'm having a severe reaction to Artex?

Official guidance states that if a severe adverse event, such as a severe allergic reaction (e.g., swelling of the face or throat) or signs of internal bleeding (e.g., bloody or black stools), is suspected, the use of the medication should be discontinued, and immediate medical help should be sought.


Q: Is it normal for Artex to take a few days to show its full effect?

Regulatory evidence suggests that drug plasma concentrations may take several doses to reach a consistent level in the body, known as steady-state. Clinical studies for chronic conditions like arthritis often track efficacy over weeks, indicating that the full symptomatic change may take longer than a single dose to become noticeable.


Q: Can taking Artex cause fluid retention or swelling?

Yes, official safety information documents that Artex can cause fluid retention, also known as edema, which is swelling of the hands, feet, or lower legs. This effect is also noted as potentially increasing the risk of heart failure, and it is a factor monitored in high-risk patients.


Q: Does Artex affect alertness or ability to drive?

Since the product labeling lists central nervous system side effects such as dizziness and drowsiness, these effects could potentially impair a patient’s alertness. Patients are advised to note how this medication affects them before engaging in activities that require full concentration.


Q: Is Artex safe for people who have had a heart attack in the past?

Official regulatory warnings state that NSAIDs increase the risk of serious cardiovascular thrombotic events, including heart attack (myocardial infarction) and stroke. This risk is considered greatest for people with pre-existing cardiovascular disease or related risk factors, and this indicates that a thorough risk assessment is necessary for these patients.


How should Artex (NSAID) be stored and disposed of?

How to Store and Dispose of Artex (NSAID)?

The official labeling mandates strict adherence to specific storage and disposal requirements to maintain product stability and ensure safety.

Regulatory Storage and Handling

Artex must be stored at Controlled Room Temperature, generally maintained between 20 C and 25 C (68 F and 77 F). The product must be protected from excess moisture and do not freeze any formulation. Keep the medication in the original container and ensure it remains tightly closed when not in use.

Stability and Safety

Do not use Artex past the printed expiration date. Furthermore, any opened liquid forms, such as the solution for injection, have a defined in-use shelf-life that must be observed. For safety, it is a mandatory requirement to keep this medication out of the sight and reach of children.

Official Disposal

Discard unused or expired Artex through an authorized drug take-back program. Disposal into wastewater or household trash is generally restricted to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Artex (NSAID) found in:

A-Z Index: